ZIM
COLL icon

Zacks Investment Management’s Collegium Pharmaceutical COLL Stock Holding History

Zacks Investment Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.91M Buy
52,672
+22,335
+74% +$763K 0.01% 369
2026
Q1 		$1M Buy
30,337
+2,204
+8% +$93.3K 0.01% 408
2025
Q4 		$1.3M Buy
+28,133
New +$1.18M 0.01% 395

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Zacks Investment Management's COLL Position: Q2 2026 in Review

Zacks Investment Management increased its Collegium Pharmaceutical (COLL) stake by 74% in Q2 2026, buying an estimated $763K and bringing the position to 52,672 shares worth $1.91M. The position accounts for 0.01% of the portfolio, ranked #369.

Zacks Investment Management first reported a position in COLL in Q4 2025 and has held it in 3 quarters since. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Zacks Investment Management held 52,672 shares of Collegium Pharmaceutical worth $1.91M as of Q2 2026.
  • Zacks Investment Management bought 22,335 Collegium Pharmaceutical shares in Q2 2026, an estimated $763K.
  • Collegium Pharmaceutical made up 0.01% of Zacks Investment Management's portfolio in Q2 2026, its #369 holding.
  • Zacks Investment Management first reported a position in Collegium Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Zacks Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.